Heart failure & cardiomyopathies

Cardiovascular magnetic resonance to differentiate veteran athlete’s heart with cavity dilatation and mild dilated cardiomyopathy

Eur Heart J Cardiovasc ImagingPublished Prospective cross-sectional study

Authors' conclusion

Septal fibrosis is rare amongst veteran athletes with LV dilation in contrast to mild DCM patients. Native T1, ECV, and RVEDVi can also discriminate between these overlapping phenotypes

Study context

Population
Participants with left ventricular ejection fraction (LVEF) > 40% and LVEDVi ≥ 110 mL/m² without ischaemic heart disease or significant cardiac pathology on cardiovascular magnetic resonance (CMR) likely to cause heart failure (HF)
Participants
113 participants
Exposure
Veteran athletes with left ventricular (LV) dilatation vs mild dilated cardiomyopathy (DCM) patients
  • Athletesn = 64
  • Mild DCMn = 49reference
Outcome
Distribution of myocardial fibrosis and patterns of tissue characteristics on CMR
Methodological detailsage-/sex-matched
  • Age-/sex-matched

Main finding

As reported in the abstract

Fibrosis distribution (participants with fibrosis)

Inferolateral fibrosis

P = 0.002

Inferoseptal fibrosis

P = 0.002

Observational data: associations, not effects.

Further findings

Native T1

P < 0.001

ECV

P < 0.001

RVEDVi

P < 0.001

OutcomeAthletesMild DCMP value
Myocardial perfusion reserve3.65 ± 1.302.76 ± 0.92P < 0.001
Stress myocardial blood flow2.09 ± 0.701.62 ± 0.66P < 0.001

Discrimination between groups (ROC analysis)

Native T1 AUC
0.89 (P < 0.001)
Extracellular volume (ECV) AUC
0.85 (P < 0.001)
RVEDVi AUC
0.81 (P < 0.001)
Stress myocardial blood flow (MBF) AUC
0.68 (P = 0.002)

Original publication

Cardiovascular magnetic resonance to differentiate veteran athlete’s heart with cavity dilatation and mild dilated cardiomyopathy. Eur Heart J Cardiovasc Imaging. Published 9 August 2025. doi:10.1093/ehjci/jeaf234

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.